Emily S. Boja

Office of the Director — United States

Chemistry · Physical Sciences

45h-index14.5kcitations115works6.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Proteomics Techniques and Applications(54), Mass Spectrometry Techniques and Applications(18), Cancer Genomics and Diagnostics(14), Ferroptosis and cancer prognosis(13), Bioinformatics and Genomic Networks(11)

Publications114 total

Making human derived data FAIR: feedback from NCI office of data sharing workshop
JNCI Journal of the National Cancer Institute·2025Open Access
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Cell·2025· 33 citedOpen Access
Abstract B047: Data Resources for Pediatric Cancer Research: Finding and Accessing Data supported by the National Cancer Institute
Cancer Research·2025
Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults
JNCI Journal of the National Cancer Institute·2025· 4 citedOpen Access
Shooting the moon: the National Cancer Institute’s implementation framework for data sharing policies
Nature Medicine·2024
Abstract 1303: Harness the power of data to improve cancer care - Understanding the complex landscape of health policies and regulations
Cancer Research·2024
Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling
Journal of Biological Chemistry·2022· 32 citedOpen Access
PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions
Cell Genomics·2022· 197 citedOpen Access
Abstract IA-003: Proteogenomic characterizations of pancreatic ductal adenocarcinoma
Cancer Research·2021
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
Frontiers in Immunology·2021· 23 citedOpen Access
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cell·2021· 559 citedOpen Access
Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling
Cell Reports Methods·2021· 20 citedOpen Access
A community effort to identify and correct mislabeled samples in proteogenomic studies
Patterns·2021· 14 citedOpen Access
Proteogenomic and metabolomic characterization of human glioblastoma
Cancer Cell·2021· 644 citedOpen Access
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Cancer Cell·2021· 356 citedOpen Access
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Cell·2020· 318 citedOpen Access
precisionFDA Truth Challenge V2: Calling variants from short- and long-reads in difficult-to-map regions
2020· 66 citedOpen Access
Statistical Design for Biospecimen Cohort Size in Proteomics-based Biomarker Discovery and Verification Studies
Figshare·2020Open Access
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays
UNC Libraries·2020Open Access
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Cell·2020· 526 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Henry Rodriguez(32), Bing Zhang(19), Christopher R. Kinsinger(18), Mehdi Mesri(18), Tara Hiltke(17), Li Ding(14), David Fenyö(14), Richard Smith(14), Karin Rodland(14), Steven A. Carr(14), Hui Zhang(13), D.R. Mani(13), Ana I. Robles(12), Amanda G. Paulovich(12), Pei Wang(11), Matthew J. Ellis(11), Mathangi Thiagarajan(11), Tao Liu(10), Karen A. Ketchum(10), D.C. Liebler(10)